Next Article in Journal
NAFLD and Hypothyroidism: Deciphering Pivotal Genetic Variants, Cellular Expression Landscapes, and Spatial Architectures
Next Article in Special Issue
Assessment of Cellular Apoptosis Induced by Hydroxychalcones in MCC13 Merkel Cells
Previous Article in Journal
Exercise-Induced Irisin: A Novel Strategy for Neuroinflammation Alleviation and Neurorepair in Diabetic Retinopathy
Previous Article in Special Issue
Dietary Polyphenols (Flavonoids) Derived from Plants for Use in Therapeutic Health: Antioxidant Performance, ROS, Molecular Mechanisms, and Bioavailability Limitations
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 27
Issue 4
10.3390/ijms27041840
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Genus Calliandra—Calliandra portoricensis, Calliandra haematocephala, Calliandra surinamensis: A Journey from Traditional Knowledge to Modern Experimental Studies in Disease Prevention and Treatment

by
Adedoyin O. Adefisan-Adeoye
1,2,*,
Samson O. Kosemani
3,
Olayinka A. Adebayo
4,
Temitope D. Adeoye
5,
Jeremiah O. Unuofin
6,
Sogolo L. Lebelo
6,* and
Oluwatosin A. Adaramoye
7
1
Pediatric Brain Tumor Program, Department of Pediatric, Hematology-Oncology Section, Baylor College of Medicine, Houston, TX 77030, USA
2
Chemical Sciences Department, Faculty of Computing and Applied Sciences, Dominion University Ibadan, Ibadan 200005, Nigeria
3
Department of Immunology, Institute of Biomedical Science, University of Sao Paulo, São Paulo 05508-220, Brazil
4
Department of Biochemistry, College of Applied and Natural Sciences, Mcpherson University, KM 96 Lagos-Ibadan Express Way, Abeokuta 110117, Nigeria
5
Federal Teaching Hospital, Ido-Ekiti 371101, Nigeria
6
Department of Life and Consumer Sciences, University of South Africa, Cnr. Christiaan de Wet and Pioneer Ave., Private Bag X6, Florida 1710, South Africa
7
Molecular Drug Metabolism and Toxicology Laboratories, Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan 200001, Nigeria
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(4), 1840; https://doi.org/10.3390/ijms27041840
Submission received: 23 November 2025 / Revised: 26 December 2025 / Accepted: 7 January 2026 / Published: 14 February 2026
(This article belongs to the Special Issue Plant-Derived Bioactives: Antioxidant Mechanisms and Preventive Health Strategies)
Browse Figures
Versions Notes

Abstract

The genus Calliandra (Leguminosae: Mimosoideae) encompasses over 200 species, many of which hold significant ethnobotanical value. However, a critical and comprehensive review consolidating their phytochemical and pharmacological knowledge is currently lacking. This article aims to provide a detailed and analytical overview of the traditional uses, phytochemistry, and pharmacological properties of the most studied Calliandra species, identifying trends, gaps, and future research priorities. A systematic literature search was conducted using Google Scholar, Scopus, Web of Science, and PubMed from 1986 to 2025. The review focuses on Calliandra portoricensis, Calliandra haematocephala, and Calliandra surinamensis due to the relative abundance of scientific literature concerning their medicinal applications. These species produce a diverse array of secondary metabolites, including distinctive galloylated flavonoids, phenolic acids, and triterpenes. Extracts and isolated compounds demonstrate a wide range of pharmacological activities, such as antioxidant, antimicrobial, anti-inflammatory, antidiabetic, and anticancer effects, providing a scientific basis for their traditional uses. The genus Calliandra represents a promising source of bioactive compounds. However, future research must focus on compound isolation, mechanistic studies, rigorous toxicological profiling, and clinical trials to fully realize its therapeutic potential.

Graphical Abstract

1. General Introduction, Distribution, Taxonomy, and Utility

The genus Calliandra (Leguminosae: Mimosoideae) comprises over 200 species distributed across tropical regions, including the Americas, Africa, Madagascar, and India [1]. A significant taxonomic revision by Arias and colleagues categorized 132 species natives to the Americas into five subsections and fourteen series [2]. In horticulture, Calliandra is represented by 6–8 exotic species, which include several intraspecific taxa and natural hybrids. Wild species such as Calliandra portoricensis (C. portoricensis) (Jacq.) Benth., Calliandra haematocephala (C. haematocephala) (Hassk), and Calliandra surinamensis (C. surinamensis) (Willd) Benth. are notable in Africa. Calliandra genera are prized for their ornamental value, primarily due to their alternate leaves and distinctive spherical flowers characterized by elongated stamen [3]. In addition, Calliandra genera are believed to be protected by a phenomenon called nyctinasty, in which its leaves fold up at night [4]. Hummingbirds love the tree’s blossoms and use its nectar as their main food source. Because Calliandra grows well in dry environments, it is a great option for xeriscaping [5,6]. The tree serves as a host plant for the larvae of butterflies, hence sustaining their numbers. Calliandra is very simple to cultivate and once established, requires very little maintenance.
Despite their popularity as garden plants, only two species within this genus have been utilized in forestry applications. Among them, Calliandra calothyrsus (C. calothyrsus) (Meisn) stands out for its adaptability to large-scale plantations, attributed to its robust coppicing ability and nitrogen-fixing properties. Beyond ornamental and forestry uses, Calliandra genera contribute to diverse ecological and economic activities, offering products such as forage, honey, and fuelwood, while also serving roles in soil erosion control and soil fertility enhancement [7]. Morphological diversity within the genus has led to reports of hybrids and cultivars, such as those involving C. haematocephala and Calliandra tweedii (Benth), which exhibits varying color forms. Additionally, a hybrid between C. calothyrsus and Calliandra houstoniana (Mill.) Standl. was identified by Chamberlain and Hubert [6]. Given the prevalence of natural hybrids and morphological variation, molecular techniques are recommended to complement morphological evidence in the identification and classification of cultivated taxa. This approach ensures accurate delimitation and enhances understanding of the genus’ extensive diversity.
Recently, there has been growing research interest on underexplored medicinal plants as potential sources for discovering new secondary metabolites, especially those with huge therapeutic potentials. This new trend is driven partly due to drug-resistant and adverse reactions to chemotherapeutic agents, where traditional synthetic methods have produced a few novel drug candidates, and increased multidrug resistance has increased the public health burden. Consequently, research has increased investigations into phyto-active compounds such as terpenoids, alkaloids, phenolics to assess their possible pharmacological activities [3]. This development is encouraged by improvements in omics high-throughput screening and in silico molecular docking, which enables the identification and secondary metabolites from a phyto library. Based on extensive use and scientific evidence, the three most researched Calliandra species are C. portoricensis, C. hematocephala, and C. sunarimensis. This review will focus on these three Calliandra genera. It will conduct a thorough search for information on traditional uses, taxonomy, phytochemistry, and pharmacological uses, emphasizing their medicinal and pharmaceutical importance.

1.1. Methodology and Review Scope

This review was compiled based on a systematic literature search conducted in online databases, including Google Scholar, Scopus, Web of Science, and PubMed. The search utilized keywords such as “Calliandra,” “Calliandra phytochemistry,” “Calliandra pharmacology,” and the specific species names, with no date restrictions applied initially, but focusing primarily on the literature from the last three decades. The PRISMA 2020 guidelines were adhered to while choosing the literature (Figure 1). Google Scholar, Scopus, Web of Science, and PubMed were used to find records. Following the elimination of duplicates, full-text eligibility was evaluated using predetermined inclusion and exclusion criteria after titles and abstracts were examined. The results were synthesized qualitatively, and no meta-analysis was carried out due to the variability in experimental designs, outcomes, and models.
While the genus is large, this review deliberately focuses on C. portoricensis, C. haematocephala, and C. surinamensis. This focused scope is justified as these three species have been the subject of the most intensive phytochemical and pharmacological investigations related to human health, forming a substantial and analyzable body of literature. Other species, such as C. calothyrsus, are more widely studied in an agroforestry context. This approach allows for a deeper, more critical analysis of the best-characterized medicinal species rather than a superficial overview of the entire genus. The inclusion criteria were peer-reviewed articles in English, while unpublished theses and non-English papers were excluded.

1.2. Traditional Uses of Calliandra Genera

Traditional uses of C. portoricensis (Jacq.), a sprawling perennial shrub belonging to the Mimosaceae family, are notable in ethnomedicine. Most of this shrub is found in the West Indians, Panama, Africa, and Mexico [6,8]. It is also present in several tropical countries, including Nigeria, Ghana, and Côte d’Ivoire. According to Akah and Nwaiwu [9] and Enwuru et al. [10], this herb has been a staple in traditional Nigerian medicine for many years. Practitioners of traditional herbal medicine use the plant as a laxative and worm expeller to treat convulsions, lumbago, constipation, gonorrhea, and more [9]. Agunu et al. [11] indicate that it possesses anticonvulsant, analgesic, antidiarrheal, antispasmodic, and antipyretic properties. C. portoricensis has received scientific validation for a range of traditional applications, including antibacterial, antiproliferative, antiulcer, and chemopreventive functions [12,13,14]. Traditional medicine practices in Nigeria extensively use C. portoricensis extracts to address diverse ailments. For instance, it treats breast engorgement, toothaches, coated tongues, swollen tonsils, tuberculosis, convulsions, diarrhea, infections, and sickle cell crises [15,16,17,18]. Besides its well-known white flowers, this plant has been utilized in traditional medicine for its anti-inflammatory, antibacterial, and antifungal properties [19,20]. Substantial findings highlighted its efficacy against fever, breast engorgement, gastrointestinal disorders, amenorrhea, and lumbago [21,22,23,24,25]. In Ghana, the root bark of C. portoricensis is combined with pepper for treating gonorrhea, alleviating headaches, and preparing ophthalmic remedies.
The medicinal properties of C. portoricensis encompass its ability to reduce fever and alleviate pain, as well as its efficacy in treating wounds, skin conditions, and respiratory issues [9,11,19,20]. Traditionally, C. portoricensis can be utilized to enhance general health and well-being through herbal preparations such as teas, tinctures, and infusions [22,23,24]. In addition to its numerous other benefits, C. portoricensis can assist with blood sugar regulation, alleviate symptoms of anxiety and depression, address digestive issues, and provide relief for snake bites [26]. Historically, powdered roots or alcoholic extracts of C. portoricensis leaves have been utilized for snake bite treatments [26]. Over time, traditional herbalists in southeastern Nigeria developed methods for effectively managing carpet viper venoms. This particular recipe, an ethanolic extract of C. portoricensis, is specifically intended for treating snakebite hemotoxins that cause hemotoxicity (e.g., the hemotoxins of true vipers like the puff adder and the carpet viper, as well as pit vipers like rattlesnakes). According to traditional herbalists, the secondary metabolites (bioactive principles) of C. portoricensis do not affect the neurotoxins from elapine snakes, such as cobras, mambas, and coral snakes [26]. Regular consumption of C. portoricensis has also been linked to improved cardiovascular health, reduced risk of various cancers, and enhanced cognitive function [9,16,17,27]. By incorporating this plant into daily routines, individuals can experience better sleep, increased vitality, and an overall higher quality of life. The antioxidant properties of C. portoricensis can help prevent cellular damage, potentially lowering the risk of chronic diseases like cancer and heart disease [28,29]. This also allows individuals more time to engage in their hobbies and spend time with loved ones. Furthermore, its traditional use as an antifungal and antiseptic agent has been reported to prevent infections, enabling individuals to maintain their overall health and dental wellness while feeling more confident and comfortable in their daily lives [12,30].
Traditionally, C. haematocephala has been used mostly for ornamental and cultural purposes. Because of its vivid red, brush-like blossoms, which are thought to be symbols of beauty, vigor, and hospitality, the plant is frequently cultivated in home gardens, institutional landscapes, and public areas. Flowering branches are utilized as decorations at social events, ceremonies, and celebrations in certain local customs [31,32]. Because it is thought of as a plant that continuously adds color and vitality to its surroundings, the plant’s lengthy flowering period further increases its cultural importance. In addition, C. haematocephala is employed as an antibacterial agent in ethnomedicine [30]. Its floral extracts demonstrate both antibacterial and anti-helminthic properties [33,34,35]. C. haematocephala has been utilized in localized folk medicine in addition to its aesthetic value, though these applications are few and mostly empirical. Leaf infusions or decoctions have long been used in some tribes to improve overall health or ease minor digestive issues. Crushed leaves or bark formulations have occasionally been administered externally to small wounds, insect bites, or skin irritations, reflecting common ethnobotanical practices that use easily accessible plants for straightforward cures [30,33,36,37]. These applications lack substantial scientific validation and are frequently impacted by knowledge of related Calliandra species. The phenolics, flavonoids, and tannins found in C. haematocephala leaf extract provide significant antibacterial activity against various bacterial strains [30,36]. The decoction of the flower extract is used as a tonic and blood purifier traditionally due to its antioxidant properties [38]. Its roots can be used to treat hemorrhoids [39]. The C. haematocephala effervescent granules have been formulated for treating stomach ulcers [40,41].
The pigment extracted from C. surinamensis flowers is used as a dye in the manufacture of certain pharmaceutically significant medications [3]. C. surinamensis is also widely recognized in ethnomedicine for its decorative and horticultural applications in the tropics. The large, multi-trunked shrub C. surinamensis possesses several distinctive characteristics [42]. Furthermore, C. surinamensis has been used traditionally as an aqueous infusion to treat fever and overall body weakness [43]. According to certain ethnomedical sources, it may have anti-inflammatory and calming effects on the respiratory tract when used to treat respiratory symptoms including cough and mild bronchial infections [44]. Specifically, stem bark is used in traditional medicine to treat various ailments and diseases, including inflammation, infections, coughs, and wounds [44]. In addition to its therapeutic uses, the plant has cultural value as an ornamental species and is occasionally included into agroforestry systems, where its capacity to fix nitrogen enhances soil fertility. Compared to other Calliandra species, there is still little scientific evidence to support the wide range of therapeutic applications suggested by traditional knowledge [45].
Generally, the genus Calliandra enjoys global prominence, albeit its limited use in Central America has spurred much speculation. Historically, Calliandra trees have played a vital role in the environment, providing unique benefits that make them invaluable members of any ecosystem. Calliandra genera engage in a symbiotic relationship with nitrogen-fixing bacteria in their roots. Consequently, they require less chemical fertilizer as they enhance soil fertility. Moreover, the colorful flowers of the tree attract pollinators such as bees, butterflies, and hummingbirds, encouraging biodiversity. Due to its ability to serve as a windbreak, improve soil quality, and provide shade, Calliandra is frequently employed in agroforestry systems. Its fast growth and high calorific value also make it a preferred source of firewood in many rural communities.

1.3. Bioactive Phytochemicals Present in C. portoricensis, C. hematocephela and C. surinamensis

The roots, leaves, and stems of the Calliandra genera are the main parts used traditionally. These parts are rich in fatty acids, phytochemicals such as saponins, flavonoids, and other active compounds, and they have a pungent fragrance, a hint of bitterness, and warming qualities [18,26]. Different parts of the Calliandra genera contain different kinds of important chemicals, making it a rich source of these compounds. A total of about 70 compounds in all have been found in different parts of C. portoricensis, C. haematocephala, and C. surinamensis by the use of Gas Chromatography–Mass Spectrometry (GC-MS) (Table 1). According to Adefisan et al. [17,27], GC-MS investigations showed that the primary ingredients in the essential compounds of C. portoricensis contained majorly 22 compounds in the methanol and chloroform extracts of C. portoricensis. Methyl-3-phenylindole, Methyl stearate, Methyl 9-cis, 11-trans-octadecadienoate, Cis-13-Octadecenoic acid, D-Fructose, 3-O-methyl-1-Octadecene, Hexadecanoic acid, methyl ester, D-Fructose, 3-0-methyl-, Thiophene, 2-ethyltetrahydro-, B-d-Mannofuranoside, methyl tetraacetate, 1-Butene, 1-(methylthio)-, Trimethylsilyl 23 acetoxy-3,6,9,12,15,18,21-heptaoxatricisan-1-oate and Methyl tetra decanoate are among the twelve major compounds identified in the C. portoricensis methanol extracts (Table 1). Adaramoye et al. [16] and Oyebode et al. [13] equally reported 10 compounds in the methanol roots and leaf extracts of C. portoricensis using GC-MS characterization. Orishadipe and associates [12] analyzed the hexane extract of C. portoricensis using GC-MS and discovered that 14-methyl methylpentadecanoate was the primary constituent (Table 1). They also reported trace quantities of fatty acids and fatty acid methyl esters, including hexadecanoic acid, methylhexadecanooate, 9-oxo-methyl nonanoate, and a few more.
Numerous analyses of C. haematocephala’s chemical components have been conducted. The leaves and stem of C. haematocephala were found to contain three acylated quercetin rhamnosides, whose structures were determined to be quercitrin 2′-O-caffeate, quercitrin 3′-O-gallate, and quercitrin 2′,3′-di-O-gallate [48] (Table 1). Also, 17 known compounds were reported from C. haematocephala stem extract by Mohorram et al. [48]; they are gallic acid, methyl gallate, myricitrin, quercitrin, myricetin 3-O-â-D-4C1-glucopyranoside, isoquercitrin, myricetin afzelin, 3-O-(6′-O-galloyl)-â-D glucopyranoside, myricitrin 2′-O-gallate, quercitrin 2′-O gallate, afzelin 2′-O-gallate, myricitrin 3′-O-gallate, afzelin 3′-O-gallate, 1,2,3,4,6-penta-O-galloyl-â-D 4C1-glucopyranose, myricitrin 2′,3′-di-O-gallate, quercetin 3-O-methyl ether [48]. In addition, Nia et al. [35] documented the identification of betulinic acid and caffeineic acid from C. haematocephala (Table 1). Overall, limited research has been done on the significant compounds of Calliandra genera based on their separation from various plant sections. Nonetheless, their pharmacological effects and other biological properties have been widely investigated.

2. Calliandra portoricensis

2.1. Morphological Description and Distribution

C. portoricensis, commonly known as powder puff, is a perennial shrub belonging to the Leguminosae family. It is well-known for its fragrant, snowball-shaped white blossoms and has many medicinal uses (Figure 2). In Nigeria, the plant is referred to as “Tude” in Yoruba, “Ule” in Igbo, and “Oga” in Hausa. Globally, the genus Calliandra encompasses over 200 species distributed across tropical and subtropical regions of the Americas, Asia, and Africa, with notable examples including C. eriophylla, C. anomala, C. haematocephala, and C. portoricensis [50]. C. portoricensis is native to Mexico, Panama, and the West Indies. It produces delicate, fluffy white flowers in the spring, which are characterized by small, inconspicuous petals and white stamens that give the flower head its fluffy snowball appearance. In cooler climates, it can be grown in glasshouses. It can grow in most soil types if they are well-drained, and it only needs occasional watering in the winter. It requires minimal pruning to maintain its shape and remove dead branches. It is vulnerable to mealy bugs and red spider mites. Despite its broad distribution and ease of cultivation, the botanical and ecological literature on C. portoricensis remains largely descriptive, with limited integration of morphological variation, ecological interactions, and phytochemical diversity. This lack of critical comparative studies makes it challenging to relate its morphological features to its medicinal potential or environmental adaptability. Future research should adopt integrative approaches via combining molecular taxonomy, ecological assessment, and chemical profiling to clarify variations and their implications for pharmacological research.

2.2. Phytochemistry of Calliandra portoricensis

The phytochemical composition of C. portoricensis has been extensively analyzed, revealing the presence of several bioactive compounds (Table 1), including alkaloids, saponins, tannins, flavonoids, polyphenols, glycosides, phlobatannins, and reducing agents [51]. However, studies indicate the absence of tannins, phlobatannins, anthraquinones, and hydroxymethyl anthraquinones in both fresh and dried C. portoricensis extracts [9]. Notably, alkaloids and glycosides are consistently identified in C. portoricensis extracts, though the role of alkaloids, often regarded as highly toxic, remains debatable regarding their significance in plant metabolism [51]. While the presence of flavonoids, steroids, polyphenols, saponins, and reducing compounds has been repeatedly confirmed (Table 1) [28,52], most studies rely on preliminary qualitative screening or GC–MS analysis, with limited follow-up through bioguided assay fractionation or structure-activity relationship studies. This limits the ability to directly correlate specific compounds with observed biological activities. A more critical and standardized approach to phytochemical characterization, integrating advanced analytical techniques and quantitative assessments, is therefore needed to fully understand the chemical basis of the plant’s ethnomedicinal uses and therapeutic potential.

2.3. Biological Activities of Calliandra portoricensis

2.3.1. Antimicrobial and Anti-Ulcer Activities

Several in vitro studies have reported the antimicrobial properties of C. portoricensis, Aguwa and Lawal [53] were the first to report that both ethanol and aqueous extract of the leaves is highly active against bacterial pathogens. Subsequently Oguegbulu et al. [54] comparatively studied five medicinal plants, including C. portoricensis, and result showed that C. portoricensis demonstrated the widest spectrum of activity, with ethyl acetate fractions showing the most potent inhibition. The zones of inhibition ranged from 14 to 22 mm, and minimum inhibitory concentrations (MICs) dropped between 25 and 100 µg/mL against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Candida albicans, surpassing ciprofloxacin and fluconazole controls. A complementary study by Orishadipe et al. [12] reported that the n-hexane root extract of the leaves inhibited S. aureus and E. coli with MICs of 100–200 µg/mL, though activity was absent against Pseudomonas aeruginosa and Bacillus subtilis. In vitro micro-dilution assay of peptide-rich and crude methanol root extracts found MIC in the low μg/mL range (e.g., MICs 12.25–50 μg/mL against MRSA and S. aureus; 25 μg/mL against E. coli in the methanol crude and peptide fractions [8]. Early pharmacological study on C. portoricensis showed that it also possesses anti-ulcer and gastro-protective activity. Intraperitoneal administration of ethanolic and aqueous leaf extracts reduced ulceration in pylorus-ligation and stress (cold-restraint) models at 50 mg/kg intraperitoneal, and the reported intraperitoneal LD50 values were 120.2 mg/kg (ethanolic) and 79.4 mg/kg (aqueous) [53]. Overall, it can be confirmed from these findings that C. portoricensis is a promising antimicrobial agent.

2.3.2. Anticonvulsant and Analgesic Activities

In traditional medicine, C. portoricensis has been employed for managing stomach disorders and convulsions. Akah and Nwaiwu [9] were among the first to document its anticonvulsant properties. In their study using pentylenetetrazole and maximal electroshock seizure models, they demonstrated that aqueous extracts from the root and stem displayed protection upon administration to experimental animals. Also, they found out that alkaloid fraction produced no anticonvulsant effect up to 316 mg/kg intraperitoneal, indicating the active anticonvulsant constituents are non-alkaloidal. Their study was further validated by [15,29]. The analgesic potential of C. portoricensis was evaluated by Agunu et al. [11] using acetic acid-induced writhing and formalin-induced pain tests in rodents. Both roots and leaves of C. portoricensis showed significant analgesic effects (when given orally at 200, 400 and 600 mg/kg), reducing abdominal cramps and formalin-provoked pain, highlighting its therapeutic promise for pain management.

2.3.3. Antioxidant and Anti-Venom Properties

The antioxidant and anti-venom properties of C. portoricensis have also drawn significant attention [14,16,17,26,27,55,56]. Ethanol extracts of C. portoricensis have long been used by herbalists in Nigeria for snakebite management. Onyeama et al. [26] evaluated Wistar rats challenged with Echis ocellatus venom (0.2 mg/rat, intramuscularly) and subsequently treated with flavonoid, polyphenol fractions, or whole ethanolic extract of C. portoricensis (100 mg/100 g body weight, intramuscular) revealed that C. portoricensis extracts mitigated oxidative stress caused by venom in rats by reducing phospholipase A2 activity from 0.2104 μmol/min/mL in venom control to 0.1195, 0.0779, and 0.0536 μmol/min/mL in flavonoid, polyphenol, and whole extracts, respectively. It also normalized liver enzyme activities (amino transferases), improved haematological indices (hemoglobin, red blood cell, white blood cell, platelets), and enhanced endogenous antioxidant defenses (superoxide dismutase, glutathione peroxidase). Co-administration of C. portoricensis was shown to reverse venom-induced hepatotoxicity and improve hemoglobin levels. Adaramoye et al. [16] also confirmed the antioxidative potential of C. portoricensis’s methanol extract in vitro, supporting its therapeutic use for oxidative stress and venom-related conditions. In addition, Adefisan and colleagues extensively documented the antioxidative activities of C. portoricensis in chemical-induced breast cancer and reproductive toxicities [14,17,27,55]. They demonstrated that the methanol root bark and chloroform fraction of C. portoricensis substantially improved antioxidant activities in mammary tumor-bearing rats.

2.3.4. Anti-Proliferative and Cytotoxic Effects

The anti-proliferative properties of C. portoricensis against cancer cells were demonstrated by Adaramoye et al. [16], who treated PC-3 and LNCaP prostate cancer cells with C. portoricensis root methanol extract at 10, 50 and 100 μg/mL. Growth inhibition (48 h) was dose-dependent: PC-3: 7% (10 μg/mL), 74% (50 μg/mL) and 92% (100 μg/mL); LNCaP: 27% (10 μg/mL), 73% (50 μg/mL) and 85% (100 μg/mL). The extract showed low toxicity at its half-inhibitory concentration and 50 μg/mL produced significant anti-angiogenic effects in the chorioallantoic membrane assay [16]. Additionally, Oyebode et al. [13] found that methanol extracts of C. portoricensis effectively inhibited the proliferation of prostate cancer cells (LNCaP and DU-145) while sparing normal VERO cells, underscoring their potential as a selective cytotoxic agent. Moreover, Adefisan et al. [27,55] used MCF-7 cells to show the anti-proliferative properties of the chloroform fraction of C. portoricensis both in vitro and in vivo. According to their findings, C. portoricensis causes MCF-7 cells to undergo apoptosis and alters the N-methyl-N-nitrosourea and benzo(a)pyrene carcinogenesis processes in rats [27,55]. Similarly, Kosemani et al. [57] and colleagues’ research also showed that the methanol fraction of C. portoricensis uses anti-inflammatory and anti-oxidative pathways to protect the mammary gland from 7,12-dimethyl-benz[a]anthracence assaults. All these findings point to C. portoricensis’ antiproliferative potential.

2.3.5. Safety and Toxicity of Calliandra portoricensis

The long-term administration of C. portoricensis root and leaf extracts has been reported to affect gastrointestinal and pancreatic functions in animal models, specifically mice and rats [4]. Acute toxicity studies by Onyeama et al. [26] examined the lethal dosage of C. portoricensis extracts. Their findings indicated significant mortality rates at administered doses of 625 mg/kg and 10,000 mg/kg. At a lower dose of 39 mg/kg, only one death was observed within 24 h, highlighting the dose-dependent toxicity of C. portoricensis. However, most toxicity studies reported are limited to acute and sub-acute animal experiments, with little emphasis on mechanistic insights, chronic exposure effects, or organ-specific toxicity investigations. Biomarkers like haematological alterations, histopathological changes, and biochemical indices have not been comprehensively assessed. Furthermore, standardized toxicity protocols and comparisons across different plant parts or extraction solvents are lacking, making it difficult to establish safe therapeutic margins. Rigorous toxicological profiling, including chronic toxicity, genotoxicity, and pharmacokinetic studies are essential to support the safe development of C. portoricensis-based therapeutic applications.

3. Calliandra haematocephala

3.1. Morphological Description and Distribution

Calliandra haematocephala (Haskk), commonly known as the powder puff tree, is an ornamental shrub or small tree reaching heights of 1–3 m from the family, Fabacea, and subfamily of Mimosoideae (Figure 3). Its glossy, pinnately compound green leaflets, with five to ten pairs, are oblong and acute [42]. The branches are brown, cylindrical, and textured. Notable for its striking flowers, the plant produces puff-like inflorescences in shades of watermelon pink, deep red, or white during warm months (Figure 3). Each flower cluster, measuring up to 7 cm in diameter, contains numerous long, silky stamens that transition from silky to dark metallic green over time. The fruit is a linear-oblanceolate pod, 6–11 cm long and 5–13 mm wide, that splits upon ripening to release oblong brown seeds [33,39]. It is indigenous to tropical America and India and can be planted in parks and gardens. While its morphological features are well-documented, the taxonomic and ecological studies on C. haematocephala remain limited, particularly on variations and adaptive traits. There is also a lack of research linking these morphological characteristics to the plant’s chemical or pharmacological properties, despite increasing interest in its medicinal potential. Comparative analyses with other Calliandra species could clarify how structural variations influence ecological interactions and secondary metabolite production. Integrating morphological, molecular, and phytochemical data would provide a more comprehensive understanding of this species beyond its ornamental value.

3.2. Phytochemical Constituents Calliandra haematocephala

Comprehensive studies reveal a diverse phytochemical profile in C. haematocephala (Table 1). Numerous phytochemical investigations of C. haematocephala have been conducted in recent decades, and the results have indicated that flavonoids, carbohydrates, alkaloids, glycosides, saponins, steroids, and tannins are among the main categories of substances found in the plant [42]. Extracts from different parts of the plant contain phenolics, flavonoids, alkaloids, saponins, tannins, glycosides, and steroids. Specific isolated compounds include lupeol, betulinic acid, and flavonoids such as quercetin, kaempferol, and myricetin. The plant’s tannins, predominantly procyanidins and prodelphinidins, show significant antioxidant potential. In addition, volatile compounds make up 93.32% of the plant’s total aromatic profile, with oxygenated constituents contributing to its biological activities [34]. Studies have identified various phytochemicals in C. haematocephala, including flavonoids, tannins, terpenoids, glycosides, and volatiles. Flavonoid glycosides such as quercetin-3-O-rhamnopyranoside, kaempferol-3-O-(2″-O-galloyl)-rhamnopyranoside, and myricetin-3-O-(2″,3″-di-O-galloyl)-rhamnopyranoside have been reported (Table 1) [37,49,58,59]. The plant’s phytochemical profile contributes to its significant biological activities.

3.3. Biological Activities of Calliandra haematocephala

3.3.1. Phytochemical Constituents, Cytoprotective, Antioxidant and Antimicrobial Potential of C. haematocephala

The bioactive profile of C. haematocephala has attracted significant scientific attention due to its diverse pharmacological activities, including antioxidants, antimicrobial, antibacterial, antifungal, anti-inflammatory, and cytoprotective properties [30,33,34,36,37]. Research has shown that both crude extracts and isolated compounds contribute to their broad therapeutic value across multiple biological systems. Moharram et al. [48] and Gupta et al. [37] identified three new acylated quercetin rhamnosides, quercitrin 2-O-caffeate, quercitrin 3-O-gallate, and quercitrin 2″,3″-di-O-gallate along with 17 known compounds. These flavonoids exhibited moderate to strong radical scavenging properties, while myricitrin and quercitrin demonstrated cytotoxic effects on Artemia salina, supporting the antioxidant and cytoprotective potential of the species. Similarly, Antony de Paula Barbosa [60] demonstrated the gastroprotective effect of butanolic extract in gastric lesions induced by acidified alcohol, where the extract reduced hemorrhage and necrosis, likely due to its cytoprotective constituents. Collectively, these studies confirm that C. haematocephala possesses potent antioxidant and cytoprotective properties, although variations in extraction methods and solvent polarity may account for differences in reported activity levels. Furthermore, antibacterial investigations by Punnagai et al. [33] revealed inhibition against Salmonella typhi (12 mm), Serratia marcescens (9 mm), and Staphylococcus aureus (9 mm), comparable to ampicillin, findings that align with those of Srishti et al. [61]. The consistency of these results underscores the broad-spectrum antimicrobial potential of the plant, though further work is needed to isolate and characterize its most active constituents.

3.3.2. Antiviral, Antihelmintic, and Hepatoprotective Activities

Beyond its antioxidant effects, C. haematocephala has demonstrated remarkable antiviral, antiparasitic, and hepatoprotective properties [58,62]. In a recent study, Shaheen et al. [58] reported that methanol extracts of C. haematocephala leaves significantly reduced mortality and diarrhea severity in rotavirus-infected mice, highlighting its potential antiviral efficacy. In parallel, Jharna Tiwari and Gopal Rai [63] observed strong anthelmintic effects from flower extracts tested against Eisenia foetida; these findings were later corroborated by Ajay Kumar Shukla [64] using Albendazole as a control. Together, these studies reveal the plant’s broad bioactivity against viral and parasitic agents, though its precise mechanism of action remains poorly defined. Additionally, Abo-Elhamd et al. [62] documented the hepatoprotective influence of total alcoholic extract against carbon tetrachloride-induced liver injury, demonstrating reductions in alanine aminotransferase, aspartate aminotransferase, and bilirubin levels. These results support the idea that the polyphenolic and flavonoid-rich composition of C. haematocephala underlies both hepatic and systemic protection, complementing its antioxidant profile.

3.3.3. Wound-Healing, Antisickling, and Antidiabetic Potentials

Emerging research has also revealed the regenerative and metabolic benefits of C. haematocephala. Gupta et al. [37] found that ethyl acetate extract of C. haematocephala leaves enhanced wound healing by increasing tensile strength, hydroxyproline, and protein levels in healed tissues. This observation is consistent with Abo-Elhamd et al. [62], who also attributed tissue protection to high flavonoid content. Such consistency suggests that the plant’s secondary metabolites are multifunctional, having antioxidant, anti-inflammatory, and wound-healing benefits. Amujoyegba et al. [15] evaluated the antisickling properties of C. haematocephala and C. portoricensis, finding that ethanolic root extract exhibited the highest inhibitory (90.19%) and reversal (92.63%) effects on sickled human red blood cells. The results indicate that the bioactive compounds in C. haematocephala possess potential for hemoglobin reconfiguration, aligning with its previously reported antioxidant activity, as oxidative stress is central to red blood cell sickling. Punnagai and Glory Josephine [39] demonstrated the alpha-amylase and alpha-glucosidase inhibitory potential of C. haematocephala leaves, suggesting its role in diabetes management. This aligns with evidence of its polyphenolic richness, as phenolic compounds are known to modulate carbohydrate metabolism. However, unlike the studies of Moharram et al. [48], which focused on quercetin derivatives, Punnagai and Glory Josephine [39] did not isolate specific constituents, leaving a gap in understanding the exact bioactive principles responsible for the antidiabetic effect.

3.3.4. Nanotechnological Applications and Anti-Inflammatory Properties

The versatility of C. haematocephala extends into nanotechnology and inflammation modulation. Raja et al. [36] synthesized silver nanoparticles from C. haematocephala leaf extract, which exhibited antibacterial activity against Escherichia coli and potential applications in biosensors. Similarly, Ramesh et al. (2020) reported the synthesis of zinc oxide nanoflowers using C. haematocephala extract, showing excellent photocatalytic dye degradation properties [65]. These studies highlight the growing use of C. haematocephala in nanotechnology-based biomedical applications, though biocompatibility and toxicity profiles remain underexplored. Abou Zeid et al. [46] demonstrated that ethanol extract of C. haematocephala aerial parts exhibited 87.80% anti-inflammatory potency, attributed to its high quercetin content. Quercetin inhibits cyclooxygenase and lipoxygenase, reducing prostaglandin and leukotriene production [46]. This mechanistic explanation supports earlier reports by Moharram et al. [48] on the anti-inflammatory contribution of flavonoids. Nevertheless, variability in experimental models and dosing regimens across studies complicates direct comparison of efficacy levels. Srishti et al. [61] showed that methanolic extracts of C. haematocephala exhibited antibacterial effects against acne-causing S. aureus and S. epidermidis, comparable to benzoyl peroxide and clindamycin. This finding strengthens the antibacterial claims of Punnagai et al. [33], but both studies lacked detailed phytochemical quantification, which limits reproducibility.

3.3.5. Pharmaceutical Formulation Potential and Future Research

Given its rich bioactive profile, C. haematocephala has also been explored for its pharmaceutical formulation potential, Gupta et al. [37] formulated herbal effervescent granules using C. haematocephala leaf extract, which demonstrated excellent flow properties, including good angle of repose, Carr’s index, and bulk density. The formulation potential of the extract further supports its pharmaceutical value. Collectively, while most studies affirm the pharmacological and technological versatility of C. haematocephala, comparative analysis reveals that methodological variations, particularly in solvent systems, assay types, and extract concentrations contribute to differences in reported efficacy. Therefore, future investigations should aim for standardized extraction and bioassay protocols to validate these promising results and facilitate clinical translation.

4. Calliandra surinamensis

4.1. Morphological Description and Distribution

Calliandra surinamensis (Wall.), a member of the Fabaceae family, is a flowering plant of significant ecological and economic importance. This evergreen, low-branching tropical shrub, commonly known as pink powder puff or Suriname powder puff, derives its name from Suriname, a country in Northern South America. Locally, it is referred to as “Kaliandra bunga merah” in Malaysia. The species is endemic to various regions, including southern Asia, Africa, Australia, and the Americas [66]. It may grow up to 5 m tall, have lovely evergreen foliage, and produces stunning pink blooms in a “powderpuff” spherical shape (Figure 4). The plant is renowned for its year-round floral display and is occasionally used as a hedge. C. surinamensis, commonly known for its use in traditional medicine, has a long history of application in treating various ailments due to its reported antioxidant and antimicrobial properties. The stem bark of C. surinamensis has been especially notable for its therapeutic potential [44]. Despite its prominence in ethnomedicine, research focusing on the chemical constituents of the plant remains limited. Preliminary studies conducted by Falodun and colleagues have identified several secondary metabolites in the root bark, including flavonoids, β-sitosterol 3-O-β-D-glucopyranoside, and recursterol, pointing to its significant phytochemical potential [67]. Similarly, research by Sikder et al. [44] highlighted the presence of flavonoid compounds in the plant’s flowers, further confirming its diverse phytochemical profile.

4.2. Biological Activities Calliandra surinamensis

4.2.1. Membrane-Stabilizing Activity and Brine Shrimp Lethality Bioassay

The membrane-stabilizing properties of C. surinamensis have been explored using erythrocyte models. This activity was demonstrated by evaluating the plant’s ability to protect mice erythrocytes from hypotonic solution- and heat-induced hemolysis. According to the method outlined by Shinde et al. [68] and modified by Sikder et al. [44], the extracts exhibited significant protective effects, with concentrations as low as 2.0 mg/mL outperforming acetylsalicylic acid, a common anti-inflammatory drug. The general toxicity of C. surinamensis was assessed through the brine shrimp lethality bioassay using Artemia salina. This one-day in vivo investigation is an effective measure of cytotoxicity, with vincristine sulfate used as the positive control. The results of this experiment provided insight into the plant’s toxicological profile, an important consideration for its safety in medicinal applications.

4.2.2. Thrombolytic and Antimicrobial Activities

The thrombolytic activity of C. surinamensis was evaluated based on the method developed by Prasad [69] and later modified by Silder et al. [44]. The plant extract demonstrated notable thrombolytic activity when compared to streptokinase, a standard thrombolytic agent. This indicates the potential of C. surinamensis in managing conditions related to clot formation, such as heart attacks and strokes. The antimicrobial properties of C. surinamensis were rigorously tested against thirteen bacterial strains and three fungal species. The disc diffusion method was employed to screen the plant extract, revealing broad-spectrum antimicrobial activity. The strains tested included Bacillus cereus, Bacillus megaterium, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and others, demonstrating the plant’s potential as a natural antimicrobial agent [70].

4.2.3. Antioxidant Activity and Phytochemical Investigation

The total phenolic content of C. surinamensis extractives was quantified using the Folin–Ciocalteu reagent, with gallic acid as the standard. Following the methodology of Skerget et al. [71], the plant exhibited a high phenolic content, which contributes to its antioxidant activity and may play a role in its various biological effects. Phytochemical studies have revealed the presence of several bioactive compounds in the flowers of C. surinamensis. Notably, three flavonol glycosides were identified: 3-O-rhamnosylkaempferol, 3-O-rhamnosylmyricetin, and Myricetin-3-O-heptoseptanoside. The molecular structures of these compounds were elucidated using advanced spectroscopic techniques, including 1D-NMR (1H, 13C, DEPT) and 2D-NMR (COSY, HMQC, HMBC). The findings were then compared with the existing literature to validate the structures and provide further insight into the phytochemical profile of the plant [70].

5. Discussion

The genus Calliandra, comprising species like C. portoricensis, C. haematocephala, and C. surinamensis, exhibits a rich ethnobotanical history as well as a wide range of biologically active compounds with potential pharmaceutical uses. The medicinal potential of these species in treating a variety of illnesses is revealed by this review, which integrates conventional knowledge with contemporary experimental findings. Over 60 compounds, including flavonoids, alkaloids, saponins, tannins, glycosides, and essential fatty acids, have been found through phytochemical studies conducted on various plant parts and extraction techniques. Antimicrobial, anti-ulcer, anticonvulsant, analgesic, antioxidant, anti-venom, and anti-proliferative properties are among the many biological actions that C. portoricensis notably demonstrates [11,13,14,16,19,20,39,58] (Table 2, Figure 5). These findings confirm its widespread application in traditional African medicine and highlight its potential for creating new therapeutic agents, especially in conditions related to oxidative stress and cancer.
Similarly, C. haematocephala has demonstrated notable wound-healing, antioxidant, cytotoxic, gastroprotective, antibacterial, antiviral, and hepatoprotective qualities (Figure 5). Its use in the development of nanoparticles increases its usefulness in environmental and medicinal applications. Its strong bioactivity is attributed to the presence of acylated quercetin rhamnosides and other flavonoids, indicating its significance in the fight against inflammatory conditions and microbial resistance. Biotechnological advancements have also opened a new approach of assessment of the therapeutic and environmental relevance of C. haematocephala used in the green synthesis of nanoparticles like zinc oxide and silver where their photocatalytic, biosensing and antimicrobial activity was determined [36]. Despite being rarely researched, C. surinamensis exhibits interesting pharmacological properties, including as thrombolytic, antibacterial, antioxidant, and membrane-stabilizing actions. The discovery of flavonol glycosides and other secondary metabolites validates their conventional application and creates opportunities for additional research in the treatment of viral and cardiovascular diseases.
There are still several gaps despite these encouraging findings. The translational application of Calliandra genera is hampered by the variation in extraction techniques, the absence of defined dosages, and the paucity of clinical evidence. Furthermore, thorough research is needed on the safety profiles, especially about pharmacokinetics and long-term toxicity. The need for thorough assessment prior to clinical application is highlighted by the dose-dependent toxicity in C. portoricensis. To determine efficacy and safety, future research should concentrate on identifying and defining the most powerful bioactive substances, clarifying their modes of action, and carrying out preclinical and clinical trials. Furthermore, incorporating molecular methods for precise taxonomic classification will improve pharmaceutical research’s dependability.
In addition, improvements in metabolomics and next generation GC-MS and LC-MS analysis have supported the identification and documentation of novel phyto-constituents both in C. haematocephala and C. portoricensis, contributing to drug discovery initiatives [67,72]. For taxonomic classification of Calliandra genus, both phylogenomic profiling and DNA barcoding have been deplored to enable precise identification of natural compounds present in the genus [2]. Computer modeling and molecular docking have made it easy to understand how Calliandra-based compounds could interact with their targeted site [73]. These novel advancements have not only supported ethnopharmacological prerogatives of Calliandra genus, but it has also been able to provide a strong approach towards translational research of viable drug candidates from Calliandra genera. The study of Calliandra genera demonstrates the potential of ethnobotanical resources in drug discovery by bringing together traditional knowledge and contemporary research. These plants could make a substantial contribution to advancing the development of sustainable, plant-based medicines that address global health issues through interdisciplinary cooperation.

6. Future Perspectives

The genus Calliandra holds immense promise for advancing natural product-based drug discovery, with species such as C. portoricensis, C. haematocephala, and C. surinamensis exhibiting rich ethnomedicinal histories and diverse bioactive profiles. As pharmacological research continues to evolve, further studies into the molecular mechanisms underlying their various biological activities are essential. Specifically, the exploration of C. portoricensis’s potential in cancer therapy, oxidative stress management, and venom-related conditions presents exciting prospects for new therapeutic agents. The plant’s promising anti-proliferative effects on cancer cells and its ability to mitigate oxidative damage and enhance endogenous antioxidant defense mechanisms suggest that it could play a significant role in managing cancer, chronic diseases, and venomous bites or stings.
Research into C. surinamensis offers a particularly intriguing future direction, as it demonstrated thrombolytic, antimicrobial, and antioxidant activities open the door for the development of novel natural agents for treating cardiovascular diseases, infections, and oxidative stress-related disorders. Further exploration of its bioactive compounds, such as flavonol glycosides, will contribute to the discovery of new drug candidates targeting inflammation, infections, and oxidative stress. Additionally, C. surinamensis’s potential as a natural thrombolytic agent could be of great interest in areas with limited access to conventional thrombolytic drugs, offering an alternative with reduced side effects.
For C. haematocephala, ongoing research into its antimicrobial, antiviral, and hepatoprotective properties presents an opportunity for the discovery of novel agents combating resistant pathogens, particularly in the face of growing antimicrobial resistance. Moreover, its potential role in nanoparticle synthesis for applications in biosensing, environmental pollution remediation, and drug delivery systems paves the way for the integration of plant-based nanotechnology into modern biomedical applications. Multidisciplinary research, incorporating pharmacology, nanotechnology, and biotechnology, will be essential in fully harnessing the therapeutic potential of these plants.
The safety profiles of these species, especially concerning their toxicological effects and pharmacokinetics, require further investigation to ensure their safe medicinal application. Comprehensive toxicity studies and long-term administration trials are necessary to evaluate potential adverse effects and establish safe dosages, facilitating their eventual clinical use. Also, molecular techniques such as omics and advanced metabolomics should be deployed to map the chemo-diversity of the Calliandra genus to identify important biosynthetic pathways and important active secondary metabolites. While some of its pharmacological (anti-inflammatory, anti-sickling, and anticancer) properties have been explored, it was discovered that most were performed in vitro. Therefore, there is a need for more in vivo mechanisms of action and pharmacological elucidation to justify observations from preliminary investigations.

7. General Conclusions

In conclusion, Calliandra genera, including C. portoricensis, C. haematocephala, and C. surinamensis, represent a valuable source of bioactive compounds with significant therapeutic potential. The diverse pharmacological properties demonstrated by these plants—ranging from antimicrobial, anti-inflammatory, and anti-cancer activities to hepatoprotective, thrombolytic, and antioxidant effects—underscore their role in addressing unmet medical needs in both modern and traditional medicine. However, to fully realize their medicinal value, future research must focus on isolating and characterizing key bioactive compounds, optimizing extraction methods, and conducting rigorous preclinical and clinical trials.
The pharmacological exploration of Calliandra genera, coupled with an understanding of their safety profiles, will be crucial in advancing their therapeutic applications. Furthermore, sustainability and ecological considerations should guide the cultivation and use of these plants, ensuring their availability for future generations. As research into the medicinal, ecological, and biotechnological applications of Calliandra genera expands, these plants have the potential to make significant contributions to the fields of pharmacology, nanotechnology, and environmental sustainability, ultimately leading to the development of new, plant-based therapeutic agents that benefit global health.

Author Contributions

A.O.A.-A.: Writing—original draft, Writing—review and editing, Visualization. S.O.K.: Writing—original draft, Writing—review and editing, Visualization. O.A.A. (Olayinka A. Adebayo): Writing—review and editing. J.O.U.: Writing—review and editing. T.D.A.: Writing—review and editing. S.L.L.: Writing—review and editing. O.A.A. (Oluwatosin A. Adaramoye): Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

The authors disclose that Microsoft Copilot (version 1.25111.85.0) was used to assist in generating original replacement images for the Calliandra species. The AI tool was used solely to create non-copyrighted, illustrative botanical images based on the morphological descriptions provided in the manuscript. No copyright or previously published images were used in the revised figures.

Conflicts of Interest

We confirm that no known conflicts of interest are associated with this publication.

Abbreviations

C. portoricensis—Calliandra portoricensis, CH—Calliandra haematocephala, CS—Calliandra surinamensis, PTZ—Pentylenetetrazole, PC—Prostate cancer, LNCaP—Lymph Node carcinoma of the prostate, DU-145—Human prostate cancer cell, VERO—Kidney cell line, GC-MS—Gas Chromatography–Mass Spectrometry.

References

  1. Mabberley, D.J. The Plant-Book: A Portable Dictionary of Vascular Plants; Cambridge University Press: Cambridge, UK, 1997. [Google Scholar]
  2. Arias, T.; Saldarriaga, J.D.; Arenas-Castro, H.; Idárraga-Piedrahita, Á.; López-Alvarez, N.; Tovar Luque, E.; Soto-Calderón, I.D. Reconstructing the Phylogeny of Calliandra sect. Androcallis (Fabaceae): Inclusion of Colombian Species, focusing on the Enigmatic Taxon Calliandra medellinensis. Syst. Bot. 2024, 49, 364–380. [Google Scholar] [CrossRef]
  3. Omar, S.M.; Ahmat, N.; Azmin, N.F.N. Three flavonol glycosides from Calliandra surinamensis Benth. Malays. J. Anal. Sci. 2016, 20, 1530–1534. [Google Scholar]
  4. Ueda, M.; Ishimaru, Y.; Takeuchi, Y.; Muraoka, Y. Plant nyctinasty—Who will decode the ‘Rosetta Stone’? New Phytol. 2019, 223, 107–112. [Google Scholar] [CrossRef]
  5. Hernández-Conrique, D.; Ornelas, J.F.; García-Franco, J.G.; Vargas, C.F. Nectar Production of Calliandra longipedicellata (Fabaceae: Mimosoideae), an Endemic Mexican Shrub with Multiple Potential Pollinators. Biotropica 2007, 39, 459–467. [Google Scholar] [CrossRef]
  6. Chamberlain, J.R. Calliandra calothyrsus: An Agroforestry Tree for the Humid Tropics; Oxford Forestry Institute: Oxford, UK, 2001; Volume 40, p. 100. [Google Scholar]
  7. Orwa, C.; Mutua, A.; Kindt, R.; Jamnadass, R.; Simons, A. Calliandra calothyrsus—Multipurpose Tree Species. Feedipedia. 2009. Available online: https://www.feedipedia.org/node/586 (accessed on 25 December 2025).
  8. Ogbole, O.O.; Ndabai, N.C.; Akinleye, T.E.; Attah, A.F. Evaluation of peptide-rich root extracts of Calliandria portoriscensis (Jacq.) Benth (Mimosaceae) for in vitro antimicrobial activity and brine shrimp lethality. BMC Complement. Med. Ther. 2020, 20, 30. [Google Scholar] [CrossRef]
  9. Akah, P.A.; Nwaiwu, J.I. Anticonvulsant activity of root and stem extracts of Calliandra portoricensis. J. Ethnopharmacol. 1988, 22, 205–210. [Google Scholar] [CrossRef]
  10. Enwuru, V.N.; Ogbonnia, S.O.; Mbaka, G.O.; Emordi, J.E.; Ota, D.A.; Onyebuchi, P. Evaluation of Histomorphological, toxicological and antimicrobial activities of Ethanolic extract of Calliandra portoricensis root in rodents. J. Pharm. Res. Int. 2017, 1, 1–13. [Google Scholar] [CrossRef]
  11. Agunu, A.; Abdurahmam, E.M.; Shok, M.; Yusuf, S.A. Analgesic activity of the roots and leaves extract of Calliandra portoricensis. Fitoterapia 2005, 76, 442–445. [Google Scholar] [CrossRef]
  12. Orishadipe, A.T.; Okogun, J.I.; Mishelia, E. Gas chromatography-mass spectrometry analysis of the hexane extract of Calliandra portoricensis and its antimicrobial activity. Afr. J. Pure Appl. Chem. 2010, 4, 131–134. [Google Scholar]
  13. Oyebode, O.T.; Owumi, S.E.; Oyelere, A.K.; Olorunsogo, O.O. Calliandra portoricensis Benth exhibits anticancer effects via alteration of Bax/Bcl-2 ratio and growth arrest in prostate LNCaP cells. J. Ethnopharmacol. 2019, 233, 64–72. [Google Scholar] [CrossRef] [PubMed]
  14. Adefisan, A.O.; Madu, J.C.; Owumi, S.E.; Adaramoye, O.A. Calliandra portoricensis ameliorates ovarian and uterine oxido-inflammatory responses in N-methyl-N-nitrosourea and benzo [a] pyrene-treated rats. Expt. Biol. Med. 2020, 245, 1490–1503. [Google Scholar] [CrossRef] [PubMed]
  15. Amujoyegbe, O.O.; Agbedahunsi, J.M.; Akanmu, M.A. Antisickling properties of two Calliandra Genera: C. portoricensis and C. haematocephala (Fabaceae). Eur. J. Med. Plants 2014, 4, 206–2019. [Google Scholar] [CrossRef]
  16. Adaramoye, O.; Erguen, B.; Oyebode, O.; Nitzsche, B.; Höpfner, M.; Jung, K.; Rabien, A. Antioxidant, antiangiogenic and antiproliferative activities of root methanol extract of Calliandra portoricensis in human prostate cancer cells. J. Integr. Med. 2015, 13, 185–193. [Google Scholar] [CrossRef]
  17. Adefisan, A.; Owumi, S.; Adaramoye, O. Root bark extract of Calliandra portoricensis (Jacq.) Benth. chemoprevents N-methyl-N-nitrosourea-induced mammary gland toxicity in rats. J. Ethnopharmacol. 2019, 233, 22–33. [Google Scholar] [CrossRef] [PubMed]
  18. Nvau, J.B.; Alenezi, S.; Ungogo, M.A.; Alfayez, I.A.; Natto, M.J.; Gray, A.I.; Igoli, J.O. Antiparasitic and cytotoxic activity of bokkosin, a novel diterpene-substituted chromanyl benzoquinone from Calliandra portoricensis. Front. Chem. 2020, 8, 574103. [Google Scholar] [CrossRef] [PubMed]
  19. Oguegbulu, N.E.; Abo, A.K.; Afieroho, O.E. Comparative Study of Antimicrobial Potentials of Leaf and Root Extracts of Calliandra portoricensis (Jacq.) Benth (Fabaceae) on Some Human Pathogens. Eur. J. Med. Plants 2020, 31, 141–151. [Google Scholar] [CrossRef]
  20. Ofokansi, M.N.; Akah, P.A. An Insight into the Ethnopharmacology and Pharmacological Properties of Calliandra portoricensis (Jacq.) Benth. Trends Nat. Prod. Res. 2025, 6, 54–59. [Google Scholar] [CrossRef]
  21. Sharaibi, O.J.; Oluwa, O.K.; Omolokun, K.T.; Ogbe, A.A.; Adebayo, A.O. Checklist of medicinal plants used by traditional women for maternal health care in Lagos State, Nigeria. J. Med. Herbs Ethnomed. 2024, 10, 1–6. [Google Scholar] [CrossRef]
  22. Burkill, H.M. The Useful Plants of West Tropical Africa, 2nd ed.; Royal Botanic Gardens, Kew: Richmond, UK, 1995; Volume 3, pp. 67–69. [Google Scholar]
  23. Gill, L.S. Ethnomedicinal Uses of Plants in Nigeria; University of Benin Press: Benin City, Nigeria, 1992; pp. 121–122. [Google Scholar]
  24. Sofowora, A. Medicinal Plants and Traditional Medicine in Africa, 3rd ed.; Spectrum Books Ltd.: Ibadan, Nigeria, 2008; pp. 238–239. [Google Scholar]
  25. Abbiw, D.K. Useful Plants of Ghana; Intermediate Technology Publications: London, UK, 1990; pp. 143–144. [Google Scholar]
  26. Onyeama, H.P.; Igile, G.O.; Mgbeje, B.I.; Eteng, M.U.; Ebong, P.E. Evaluation of the biochemical and anti-snake venom effects of Calliandra portoricensis extract fractions in wistar rat models challenged with venom of carpet viper (Echis ocellatus). Biochemistry 2013, 3, 441–449. [Google Scholar]
  27. Adefisan-Adeoye, A.O.; Akinleye, T.E.; Adewumi, O.M.; Adeniji, J.A.; Adaramoye, O.A. Antimammary Tumour Effects of Calliandra portoricensis Fraction via Pro-Apoptotic and Anti-Inflammatory Actions in Female Wistar Rats. Saudi J. Biomed. Res. 2024, 9, 182–196. [Google Scholar] [CrossRef]
  28. Hassan, B.O.; Ese, S.O.; Kehinde, A.J. Assessment of cytotoxicity, antioxidant and free radical scavenging activities of the ethylacetate extract of Calliandra portoricensis root bark. Int. J. Pharm. Sci. Res. 2013, 4, 1800–1807. [Google Scholar]
  29. Akah, P.A.; Nwambie, A.I.; Gamaniel, K.S.; Wambebe, C. Experimental study of the anticonvulsant plants used for treatment of infantile convulsion in Nigeria. Brain Res. Bull. 1997, 44, 611–613. [Google Scholar] [CrossRef] [PubMed]
  30. Brenner, S.A.; Romeo, J.T. Fungitoxic effects of nonprotein imino acids on growth of saprophytic fungi isolated from the leaf surface of Calliandra haematocephala. Appl. Environ. Microbiol. 1986, 51, 690–693. [Google Scholar] [CrossRef]
  31. Calliandra haematocephala Hassk.: Ornamental Shrub Profile. Flora Tropical. 2020. Available online: https://www.floratropical.com/wp-content/uploads/2020/08/Ornamental-Plants-Overall-Template-Shrub-Calliandra-haematocephala-1.pdf (accessed on 25 December 2025).
  32. Calliandra haematocephala (Red Powder Puff): Plant Profile. Au Bois Vert Botanical Garden, Madagascar. Available online: https://auboisvert.com/en/plantes/pink-powder-puff/ (accessed on 25 December 2025).
  33. Punnagai, K.; Muthiah, N.S. In vitro antibacterial activity of ethanolic extract of ‘Calliandra haematocephala’ against selected bacterial strains. Biomed. Pharmacol. J. 2017, 10, 1279–1284. [Google Scholar] [CrossRef]
  34. Iftikhar, K.; Luqman, M.; Mahmood, M.S. Phytochemical analysis of leaf extract of Calliandra haematocephala and in vitro antibacterial activity against food borne bacteria. J. Glob. Innov. Agric. Soc. Sci. 2020, 8, 26–29. [Google Scholar] [CrossRef]
  35. Nia, R.; Adesanya, S.A.; Okeke, I.N.; Illoh, H.C.; Adesina, S.J. Antibacterial constituents of Calliandra haematocephala. Niger. J. Nat. Prod. Med. 1999, 3, 58–60. [Google Scholar] [CrossRef]
  36. Raja, S.; Ramesh, V.; Thivaharan, V. Green biosynthesis of silver nanoparticles using Calliandra haematocephala leaf extract, their antibacterial activity and hydrogen peroxide sensing capability. Arab. J. Chem. 2017, 10, 253–261. [Google Scholar] [CrossRef]
  37. Gupta, R.; Garg, A.; Sharma, P.; Pandey, P. Wound healing and antioxidant effect of leaves on incision Calliandra haematocephala and excision wound models. Asian J. Pharm. Pharmacol. 2016, 2, 34–39. [Google Scholar]
  38. Deshmukh, S.; Jadhav, R.; Deshmukh, M.; Deshmukh, D. A Comprehensive Review on the Therapeutic Potential of Calliandra haematocephala Hassk (Red Powder Puff). Int. J. Nov. Res. Dev. 2024, 9, 567–575. [Google Scholar]
  39. Punnagai, K.; Glory Josephine, I. Alpha-Amylase and Alpha-Glucosidase Inhibitory Effects of Calliandra haematocephala and its Potential Role in Diabetes mellitus. Asian J. Pharm. Clin. Res. 2018, 11, 429–432. [Google Scholar]
  40. Gupta, R.; Garg, A.; Sharma, P.; Pandey, P. Formulation and Evaluation of Calliandra haematocephala Effervescent Granules for Treatment of Gastric Ulcer. Int. J. Pharm. Sci. Res. 2013, 4, 3585–3590. [Google Scholar]
  41. de Paula, A.C.B.; Fonseca, M.J.V.; Saad, M.J.A.; Vilela, L.; Cunha, F.Q.; Silva, R.M. Gastroprotective Activity of the Butanolic Extract of Calliandra haematocephala Leaves in Acute Gastric Lesion Models. J. Ethnopharmacol. 2012, 141, 330–335. [Google Scholar]
  42. Nevling, L.I.; Elias, T.S. Calliandra haematocephala: History, morphology, and taxonomy. J. Arnold Arbor. 1971, 52, 69–85. [Google Scholar] [CrossRef]
  43. Duke, J.A. Handbook of Medicinal Herbs, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2002. [Google Scholar]
  44. Sikder, M.A.A.; Kaisar, M.A.; Rashid, M.A.; Millat, M.S.; Sultana, A. In vitro membrane stabilizing activity, total phenolic content, cytotoxic, thrombolytic and antimicrobial activities of Calliandra surinamensis (Wall.). J. Pharmacog. Phytochem. 2012, 1, 45–50. [Google Scholar]
  45. Fabricant, D.S.; Farnsworth, N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109, 69–75. [Google Scholar]
  46. Abou Zeid, A.H.S.; Hifnawy, M.S.; Sleem, A.A.; Mohamed, R.S. Chemical constituents and anti-inflammatory activity of the aerial parts of Calliandra haematocephala Hassk. Planta Medica 2007, 73, P_009. [Google Scholar] [CrossRef]
  47. Alenezi, S.; Igoli, N.P.; Gray, A.I.; Oaikhena, E.E.; Alfayez, I.A.; de Koning, H.P.; Igoli, J.O. Antitrypanosomal and antileishmanial activity of compounds from some Nigerian plants. Exp. Parasitol. 2024, 266, 108844. [Google Scholar] [CrossRef]
  48. Moharram, F.A.; Marzouk, M.S.A.; Ibrahim, M.T.; Mabry, T.J. Antioxidant galloylated flavonol glycosides from Calliandra haematocephala. Nat. Prod. Res. 2006, 20, 927–934. [Google Scholar] [CrossRef] [PubMed]
  49. Wei, S.; Chen, H.; Lin, Y. Comparison of chemical compositions and antioxidant activities of condensed tannins from different parts of Calliandra haematocephala. J. Wood Chem. Technol. 2015, 35, 193–206. [Google Scholar] [CrossRef]
  50. Lawal, B.A.; Moody, J.O. Evaluation of the antisickling potentials of Calliandra portoricensis (Jacq) Benth (Mimosaceae) root: Hemoglobin polymerization inhibition activity. Niger. J. Pharm. Res. 2015, 11, 66–72. [Google Scholar]
  51. Gbadamosi, I.T.; Erinoso, S.M. A review of twenty ethnobotanicals used in the management of breast cancer in Abeokuta, Ogun State, Nigeria. Afri. J. Pharm. Pharmacol. 2016, 10, 546–564. [Google Scholar] [CrossRef]
  52. Siemuri, E.O.; Akintunde, J.K.; Salemcity, A.J. Effects of sub-acute methanol extract treatment of Calliandra portoricensis root bark on antioxidant defence capacity in an experimental rat model. J. Basic Clin. Physiol. Pharmacol. 2015, 26, 375–382. [Google Scholar] [CrossRef]
  53. Aguwa, C.N.; Lawal, A.M. Pharmacologic studies on the active principles of Calliandra portoricensis leaf extracts. J. Ethnopharmacol. 1988, 22, 63–71. [Google Scholar] [CrossRef]
  54. Oguegbulu, E.N.; Abo, A.K.; Afieroho, O.E. Comparative Evaluation of the Antimicrobial Activities of some plants used in Natural Medicine–Spondiasmombin, Calliaidra portoricensiss, Dennettia tripetala, Anthocleista djalonensis and Cronton zambesicus. Saudi J. Pathol. Microbiol. 2020, 5, 257–262. [Google Scholar]
  55. Adefisan, A.O.; Owumi, S.E.; Soetan, K.O.; Adaramoye, O.A. Chloroform extract of Calliandra portoricensis inhibits tumourigenic effect of N-methyl-N-nitrosourea and benzo (a) pyrene in breast experimental cancer. Drug Chem. Toxicol. 2022, 45, 2424–2438. [Google Scholar] [CrossRef] [PubMed]
  56. Ese, S.O.; Oyewale, A.A.; Omolara, K.R.; Nyiam, E.B. Cardioprotective activity of Calliandra portoricensis leaf ethanol extract against kerosene vapour induced cardiotoxicity in male albino rats. Univers. J. Pharm. Res. 2023, 8, 39–46. [Google Scholar] [CrossRef]
  57. Kosemani, S.O.; Bakare, A.A.; Adaramoye, O.A. Fraction from Calliandra portoricensis reduces 7, 12 dimethylbenz (a) anthracene-induced mammary tumors in Wistar rats. Avicenna J. Phytomed. 2022, 12, 131–144. [Google Scholar]
  58. Shaheen, M.; Mostafa, S.; El-Esnawy, N. Anti-rotaviral effects of Calliandra haematocephala leaf extracts in-vitro and in-vivo. J. Virol. Antivir. Res. 2015, 4, 1–7. [Google Scholar] [CrossRef]
  59. Ashour, H.A.; Heider, S.M.; Soliman, M.M. Morphological and physiological responses of Calliandra haematocephala to water salinity stress and vermicompost. Ornam. Hortic. 2023, 29, 150–162. [Google Scholar] [CrossRef]
  60. Barbosa, A.D.P. Gastroprotective and immunoadjuvant activities of butanolic extract of Calliandra haematocephala. J. Med. Plant Res. 2014, 8, 727–730. [Google Scholar]
  61. Srishti, M.; Shubhi, G.; Shashank, A.; Tripti, B. Antibacterial effects of Callistemon lanceolatus and Calliandra haematocephala on acne vulgaris. Eur. J. Biomed. Pharm. Sci. 2017, 4, 631–635. [Google Scholar]
  62. Abo-Elhamd, A.M.; Aboul-Enein, A.M.; Mohamed, S.M.; Shalaby, A.S.; Konsowa, U.; Hassan, E.M.; Metwally, N.S. Chemical characterization, antioxidant, and antihepatotoxic activities of Calliandra haematocephala (Hassk.), growing in Egypt. CABI Digit. Libr. 2016, 8, 828–845. [Google Scholar]
  63. Tiwari, J.; Rai, G. In vitro investigation of anti-microbial and anti-helmintic activitiy of extract obtained from flowers of the shrub Calliandra haematocephala. Environ. Microbiol. 1986, 51, 690–693. [Google Scholar]
  64. Shukla, A.K.; Shukla, R.; Pandey, V. Evaluation of antimicrobial activity of Selaginella bryopteris. Asian J. Pharm. Pharmacol. 2017, 3, 50–52. [Google Scholar]
  65. Ramesh, V.; Raja, S.; Thivaharan, V. Green synthesis of zinc oxide nanoflowers using Calliandra haematocephala extract and evaluation of their photocatalytic dye degradation efficiency. Mater. Today Proc. 2020, 22, 1036–1041. [Google Scholar]
  66. Alzahrani, A.; Abbott, G.; Young, L.C.; Igoli, J.; Gray, A.I.; Ferro, V.A. Phytochemical and biological investigation of Calliandra surinamensis as a potential treatment for diabetes. Planta Medica 2016, 82, P385. [Google Scholar] [CrossRef]
  67. Falodun, A.; Uzoekwe, A.S.; Shengxiang, Q. Phytochemical, Anticancer and Antioxidant Evaluation of Potential Chemical Consituents of Calliandria surinamensis. Niger. J. Biotech. 2010, 21, 55–59. [Google Scholar]
  68. Shinde, U.A.; Phadke, A.S.; Nair, A.M.; Mungantiwar, A.A.; Dikshit, V.J.; Saraf, M.N. Membrane stabilizing activity, a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia 1999, 70, 251–257. [Google Scholar] [CrossRef]
  69. Prasad, S.; Kashyap, R.S.; Deopujari, J.Y.; Purohit, H.J.; Taori, G.M.; Daginawala, H.F. Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb. J. 2006, 4, 14. [Google Scholar] [CrossRef]
  70. Maurya, S.R.; Haji, A.S.; Shah, N. Solvent-based comparative analysis of antioxidant and antimicrobial activities in Calliandra haematocephala extracts. Plants Sci. J. 2024, 12, 318–324. [Google Scholar] [CrossRef]
  71. Skerget, M.; Kotnik, P.; Hadolin, M.; Hraš, A.R.; Simonič, M.; Knez, Z. Phenols, proanthocyanidins, flavones and flavonols in some plant materials and their antioxidant activities. Food Chem. 2005, 89, 191–198. [Google Scholar] [CrossRef]
  72. Falodun, J.A.; Obafemi, T.O.; Akinmoladun, A.C.; Olaleye, M.T.; Boligon, A.A.; Athayde, M.L. High-performance liquid chromatography (HPLC) fingerprinting and comparative antioxidant properties of root bark and leaf extracts of Calliandra portoricensis. Pharmacology 2018, 9, 24–44. [Google Scholar]
  73. Naveed, M.; Ali, I.; Aziz, T.; Javed, K.; Saleem, A.; Hanif, N.; Alharbi, M. Investigating the anti-cancer compounds from Calliandra harrisii for precision medicine in pancreatic cancer via in-silico drug design and GC-MS analysis. Z. Naturforschung C 2024, 79, 209–220. [Google Scholar] [CrossRef] [PubMed]
Ijms 27 01840 g001
Figure 1. The PRISMA 2020 flow chart illustrates how studies on C. portoricensis, C. haematocephala, and C. surinamensis are identified, screened, eligible, and included in the systematic review of phytochemical and pharmacological investigations.
Figure 1. The PRISMA 2020 flow chart illustrates how studies on C. portoricensis, C. haematocephala, and C. surinamensis are identified, screened, eligible, and included in the systematic review of phytochemical and pharmacological investigations.
Ijms 27 01840 g001
Ijms 27 01840 g002
Figure 2. Botanical representation of Calliandra portoricensis.
Figure 2. Botanical representation of Calliandra portoricensis.
Ijms 27 01840 g002
Ijms 27 01840 g003
Figure 3. Morphological features of the leaves and flowers of Calliandra haematocephala.
Figure 3. Morphological features of the leaves and flowers of Calliandra haematocephala.
Ijms 27 01840 g003
Ijms 27 01840 g004
Figure 4. Leaf and floral morphology of Calliandra surinamensis.
Figure 4. Leaf and floral morphology of Calliandra surinamensis.
Ijms 27 01840 g004
Ijms 27 01840 g005
Figure 5. Schematic diagram showing summary of C. portoricensis, C. hematocephela and C. surinamensis biological activities.
Figure 5. Schematic diagram showing summary of C. portoricensis, C. hematocephela and C. surinamensis biological activities.
Ijms 27 01840 g005
Table 1. Specific Phytochemical compounds identified in C. portoricensis, C. hematocephela and C. surinamensis.
Table 1. Specific Phytochemical compounds identified in C. portoricensis, C. hematocephela and C. surinamensis.
Compound NumberCompound NameChemical ClassPlant PartExtraction SolventIdentification MethodReferences
Fatty Acids and Derivatives
C-1Hexadecanoic acid (Palmitic acid)Fatty AcidLeaves, Root & BarkHexaneConfirmed (GC-MS vs. Standard)[26,46]
C-2Hexadecanoic acid, methyl esterFatty Acid EsterRoot barkMethanolTentative (GC-MS/NIST)[17]
C-3Hexadecanoic acid ethyl esterFatty Acid EsterRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-4Tetradecanoic acidFatty AcidRootChloroformTentative (GC-MS/NIST)[27]
C-5Methyl tetradecanoateFatty Acid EsterRoot barkMethanolTentative (GC-MS/NIST)[17]
C-6Linoleic AcidFatty AcidRoot, LeavesHexane, Ethyl acetate, MethanolConfirmed (GC-MS vs. Standard)[46,47]
C-7Linolenic acidFatty AcidLeavesHexaneConfirmed (GC-MS vs. Standard)[46]
C-8Oleic acidFatty AcidLeavesHexaneConfirmed (GC-MS vs. Standard)[46]
C-9cis-13-Octadecenoic acidFatty AcidRoot barkMethanolTentative (GC-MS/NIST)[17]
C-10Methyl 9-cis, 11-trans-octadecadienoateFatty Acid EsterRoot barkMethanolTentative (GC-MS/NIST)[17]
C-119-Hexadecenoic acid methyl esterFatty Acid EsterRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-126-Octadecenoic acid methyl esterFatty Acid EsterRootChloroformTentative (GC-MS/NIST)[27]
C-13Z-7-Tetradecenoic acidFatty AcidRootChloroformTentative (GC-MS/NIST)[27]
C-1414-Methylpentadecanoic acid methyl esterFatty Acid EsterRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-1514-Methylhexadecanoic acid methyl esterFatty Acid EsterRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-16Methyl stearateFatty Acid EsterRoot barkMethanolTentative (GC-MS/NIST)[17]
Phenolic Acids
C-17Gallic acidPhenolic AcidRoot bark, Stem, LeavesMethanol, Ethyl AcetateConfirmed (NMR/HPLC)[13,48]
C-18Methyl gallatePhenolic Acid EsterStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-19p-Hydroxybenzoic acidPhenolic AcidBarkEthyl AcetateConfirmed (NMR/HPLC)[35]
C-20Protocatechuic acidPhenolic AcidBarkEthyl AcetateConfirmed (NMR/HPLC)[35]
C-21Caffeic acidPhenolic AcidBarkEthyl AcetateConfirmed (NMR/HPLC)[35,48]
C-22Ferulic AcidHydroxycinnamic AcidRoot barkMethanolTentative (GC-MS/NIST)[13]
Flavonoids & Tannins
C-23CatechinFlavan-3-olTwigs, Stem barkAcetoneConfirmed (NMR)[49]
C-24EpicatechinFlavan-3-olTwigs, Stem barkAcetoneConfirmed (NMR)[49]
C-25Epigallocatechin Flavan-3-olLeavesAcetoneConfirmed (NMR)[49]
C-26Epigallocatechin-3-O-gallateFlavan-3-ol GallateLeaves, Twigs, Stem barkAcetoneConfirmed (NMR)[49]
C-27AfzelechinFlavan-3-olRoot barkMethanolTentative (GC-MS/NIST)[13]
C-28Quercitrin (Quercetin-3-O-rhamnoside)Flavonol GlycosideStem, Leaves, Aerial partsEthyl AcetateConfirmed (NMR)[46,48]
C-29Myricitrin (Myricetin-3-O-rhamnoside)Flavonol GlycosideStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-30Isoquercitrin (Quercetin-3-O-glucoside)Flavonol GlycosideStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-31Afzelin (Kaempferol-3-O-rhamnoside)Flavonol GlycosideStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-32AstilbinFlavanone GlycosideBarkEthyl AcetateConfirmed (NMR)[35]
C-33NeoisoastilbinFlavanone GlycosideBark EthylAcetateConfirmed (NMR)[35]
C-34 Catechin-3-O-rhamnosideFlavan-3-ol GlycosideBark Ethyl AcetateConfirmed (NMR)[35]
C-35MyricetinFlavonolAerial partsEthyl AcetateConfirmed (NMR/HPLC)[46]
C-36KaempferolFlavonolAerial partsEthyl AcetateConfirmed (NMR/HPLC)[46]
C-37Quercetin 3-O-methyl etherFlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-38Myricetin 3-O-β-D-glucopyranosideFlavonol GlycosideStem, LeavesEthyl AcetateConfirmed (NMR)[48]
Galloylated Flavonoids—A key feature
C-39Myricitrin 2″-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-40Myricitrin 3″-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-41Myricitrin 2″,3″-di-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-42Quercitrin 2″-O-gallate Galloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-43Quercitrin 2″,3″-di-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-44Afzelin 2″-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-45Afzelin 3″-O-gallateGalloylated FlavonolStem, LeavesEthyl AcetateConfirmed (NMR)[48]
C-46Myricetin-3-O-(2″,3″-di-O-galloyl)-rhamnopyranosideGalloylated FlavonolAerial partsEthyl AcetateConfirmed (NMR)[46]
C-47Keampferol-3-O-(2″-O-galloyl)-rhamnopyranosideGalloylated FlavonolAerial partsEthyl AcetateConfirmed (NMR)[46]
C-481,2,3,4,6-penta-O-galloyl-β-D-glucopyranoseHydrolyzable TanninStem, LeavesEthyl AcetateConfirmed (NMR)[48]
Terpenes & Steroids
C-49LupeolTriterpenoidRoot, LeavesHexane, Ethyl acetate, MethanolConfirmed (NMR)[46,47]
C-50SpinasteroneSteroidRootHexane, Ethyl acetate, MethanolConfirmed (NMR)[47]
C-51SqualeneTriterpenoidRootChloroformTentative (GC-MS/NIST)[27]
Other Compounds
C-52ZapotinBenzopyranRoot barkMethanolTentative (GC-MS/NIST)[13]
C-53LunularinDihydrostilbenoidRoot barkMethanolTentative (GC-MS/NIST)[13]
C-54EquolIsoflavanRoot barkMethanolTentative (GC-MS/NIST)[13]
C-551-Methyl-3-phenylindoleIndole DerivativeRoot barkMethanolTentative (GC-MS/NIST)[17]
C-56Hydroxymethyl anthraquinoneAnthraquinoneRoot, LeavesCrude MethanolTentative (Color Test/GC-MS)[26]
Aliphatic Hydrocarbons
C-57UndecaneHydrocarbonRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-58DodecaneHydrocarbonRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-59TetradecaneHydrocarbonRoot & BarkHexaneTentative (GC-MS/NIST)[26]
C-601-OctadeceneHydrocarbonRoot barkMethanolTentative (GC-MS/NIST)[17]
C-611,8,11-HeptadecatrieneHydrocarbonRootChloroformTentative (GC-MS/NIST)[27]
C-621,19-EicosadieneHydrocarbonRootChloroformTentative (GC-MS/NIST)[27]
Generic classes detected only by color tests (e.g., Alkaloids, Saponins) have been removed and are discussed in the text for context. Compound numbers (e.g., C-1, C-2) correspond to the chemical structures presented in a separate, standardized figure.
Table 2. Summary of phytochemicals and biological activities of C. portoricensis, C. haematocephala, and C. surinamensis.
Table 2. Summary of phytochemicals and biological activities of C. portoricensis, C. haematocephala, and C. surinamensis.
Calliandra GenusKey PhytochemicalsBiological Activity
C. portoricensisFatty Acids & Esters: Hexadecanoic acid (Palmitic acid), Methyl stearate, Linoleic acid, Oleic acid, cis-13-Octadecenoic acid.
Phenolic Acids: Gallic acid, Ferulic Acid.
Flavonoids & Tannins: Catechin, Epicatechin, Afzelechin.
Terpenes & Steroids: Squalene.
Other Compounds: Zapotin, Lunularin, Equol, 1-Methyl-3-phenylindole, Hydroxymethyl anthraquinone. Aliphatic Hydrocarbons: 1-Octadecene, Undecane, Dodecane, Tetradecane
  • Antimicrobial & Anti-Ulcer—Active against S. aureus, E. coli, K. pneumoniae, C. albicans; gastroprotective in ulcer models.
  • Anticonvulsant & Analgesic—Protective in pentylenetetrazole and electroshock models; reduces pain in writhing and formalin tests.
  • Antioxidant & Anti-Venom—Mitigates oxidative stress; reverses venom-induced hepatotoxicity and hematological alterations.
  • Anti-Proliferative & Cytotoxic—Inhibits growth of prostate (PC-3, LNCaP, DU-145) and breast (MCF-7) cancer cells; induces apoptosis.
C. haematocephalaPhenolic Acids: Gallic acid, Methyl gallate, p-Hydroxybenzoic acid, Protocatechuic acid, Caffeic acid.
Flavonoids & Tannins: Quercitrin, Myricitrin, Isoquercitrin, Afzelin, Myricetin, Kaempferol, Catechin, Epicatechin, Epigallocatechin.
Galloylated Flavonoids: Quercitrin 2″-O-gallate, Myricitrin 2″,3″-di-O-gallate, Afzelin 2″-O-gallate, 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose.
Terpenes & Steroids: Lupeol, Betulinic acid.
  • Antioxidant & Cytoprotective— Strong radical scavenging; protects against gastric lesions.
  • Antimicrobial & Antiviral—Antibacterial against S. typhi, S. aureus, E. coli; reduces rotavirus severity.
  • Anti-inflammatory & Hepatoprotective—High anti-inflammatory potency (87.80%); protects against CCl4-induced liver injury.
  • Wound Healing & Antidiabetic— Enhances wound tensile strength; inhibits α-amylase and α-glucosidase.
  • Antisickling—High inhibitory and reversal effects on sickled red blood cells.
  • Nanomedicine—Used in green synthesis of silver and zinc oxide nanoparticles with antibacterial properties.
C. surinamensisFlavonoids & Tannins: 3-O-Rhamnosylkaempferol, 3-O-Rhamnosylmyricetin, Myricetin-3-O-heptoseptanoside, Astilbin, Neoisoastilbin, Catechin-3-O-rhamnoside.Thrombolytic—Shows notable clot-dissolving activity.
  • Antimicrobial—Broad-spectrum activity against Gram-positive and Gram-negative bacteria.
  • Antioxidant—High total phenolic content contributing to free radical scavenging.
  • Cytotoxic—Exhibits toxicity in brine shrimp lethality assay.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Adefisan-Adeoye, A.O.; Kosemani, S.O.; Adebayo, O.A.; Adeoye, T.D.; Unuofin, J.O.; Lebelo, S.L.; Adaramoye, O.A. Genus Calliandra—Calliandra portoricensis, Calliandra haematocephala, Calliandra surinamensis: A Journey from Traditional Knowledge to Modern Experimental Studies in Disease Prevention and Treatment. Int. J. Mol. Sci. 2026, 27, 1840. https://doi.org/10.3390/ijms27041840

AMA Style

Adefisan-Adeoye AO, Kosemani SO, Adebayo OA, Adeoye TD, Unuofin JO, Lebelo SL, Adaramoye OA. Genus Calliandra—Calliandra portoricensis, Calliandra haematocephala, Calliandra surinamensis: A Journey from Traditional Knowledge to Modern Experimental Studies in Disease Prevention and Treatment. International Journal of Molecular Sciences. 2026; 27(4):1840. https://doi.org/10.3390/ijms27041840

Chicago/Turabian Style

Adefisan-Adeoye, Adedoyin O., Samson O. Kosemani, Olayinka A. Adebayo, Temitope D. Adeoye, Jeremiah O. Unuofin, Sogolo L. Lebelo, and Oluwatosin A. Adaramoye. 2026. "Genus Calliandra—Calliandra portoricensis, Calliandra haematocephala, Calliandra surinamensis: A Journey from Traditional Knowledge to Modern Experimental Studies in Disease Prevention and Treatment" International Journal of Molecular Sciences 27, no. 4: 1840. https://doi.org/10.3390/ijms27041840

APA Style

Adefisan-Adeoye, A. O., Kosemani, S. O., Adebayo, O. A., Adeoye, T. D., Unuofin, J. O., Lebelo, S. L., & Adaramoye, O. A. (2026). Genus Calliandra—Calliandra portoricensis, Calliandra haematocephala, Calliandra surinamensis: A Journey from Traditional Knowledge to Modern Experimental Studies in Disease Prevention and Treatment. International Journal of Molecular Sciences, 27(4), 1840. https://doi.org/10.3390/ijms27041840

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop